FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marco Gianfriddo

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Activities & Behaviors

Motor Activity

Co-author Network

Publications

TOP 3
Lara Rossini; Yuichi Hashimoto; Hiroaki Suzuki; Megumi Kurita; Marco Gianfriddo; Carla Scali; Renza Roncarati; Davide Franceschini; Giuseppe Pollio; Lorenza Trabalzini; Georg C Terstappen; Masaaki Matsuoka; Andrea Caricasole
VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin.
Vanessa Pitozzi; Michela Jacomelli; Mohamed Zaid; Cristina Luceri; Elisabetta Bigagli; Maura Lodovici; Carla Ghelardini; Elisa Vivoli; Monica Norcini; Marco Gianfriddo; Sonia Esposto; Maurizio Servili; Guido Morozzi; Elisabetta Baldi; Corrado Bucherelli; Piero Dolara; Lisa Giovannelli
Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats.
Maria Cristina Rosi; Ilaria Luccarini; Cristina Grossi; Anna Fiorentini; Maria Grazia Spillantini; Antonella Prisco; Carla Scali; Marco Gianfriddo; Andrea Caricasole; Georg C Terstappen; Fiorella Casamenti
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marco Gianfriddo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Lara Rossini; Yuichi Hashimoto; Hiroaki Suzuki; Megumi Kurita; Marco Gianfriddo; Carla Scali; Renza Roncarati; Davide Franceschini; Giuseppe Pollio; Lorenza Trabalzini; Georg C Terstappen; Masaaki Matsuoka; Andrea Caricasole
VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(6):1983-2000.
2010: Vanessa Pitozzi; Michela Jacomelli; Mohamed Zaid; Cristina Luceri; Elisabetta Bigagli; Maura Lodovici; Carla Ghelardini; Elisa Vivoli; Monica Norcini; Marco Gianfriddo; Sonia Esposto; Maurizio Servili; Guido Morozzi; Elisabetta Baldi; Corrado Bucherelli; Piero Dolara; Lisa Giovannelli
Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats.
The British journal of nutrition 2010;103(11):1674-83.
2010: Maria Cristina Rosi; Ilaria Luccarini; Cristina Grossi; Anna Fiorentini; Maria Grazia Spillantini; Antonella Prisco; Carla Scali; Marco Gianfriddo; Andrea Caricasole; Georg C Terstappen; Fiorella Casamenti
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.
Journal of neurochemistry 2010;112(6):1539-51.
2009: A M Pugliese; C Traini; S Cipriani; Marco Gianfriddo; Tommaso Mello; M G Giovannini; Andrea Galli; Felicita Pedata
The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
British journal of pharmacology 2009;157(5):818-30.
2009: Wolfgang Fecke; Marco Gianfriddo; Giovanni Gaviraghi; Georg C Terstappen; Freddy Heitz
Small molecule drug discovery for Huntington's Disease.
Drug discovery today 2009;14(9-10):453-64.
2009: Renza Roncarati; Carla Scali; thomas Comery; Steven M Grauer; Suzan Aschmi; Hendrick Bothmann; Brian Jow; Dianne Kowal; Marco Gianfriddo; Cody Kelley; Ugo Zanelli; Chiara Ghiron; Simon Haydar; John Dunlop; Georg C Terstappen
Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
The Journal of pharmacology and experimental therapeutics 2009;329(2):459-68.
2008: S Cipriani; Elisa Bizzoco; Marco Gianfriddo; Alessia Melani; Maria Giuliana Vannucchi; Felicita Pedata
Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice.
Experimental neurology 2008;213(1):163-70.
2008: Letizia Corsani; Elisa Bizzoco; Felicita Pedata; Marco Gianfriddo; Maria-Simonetta Faussone-Pellegrini; Maria Giuliana Vannucchi
Inducible nitric oxide synthase appears and is co-expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion.
Experimental neurology 2008;211(2):433-40.
2007: Maria Giuliana Vannucchi; Elisa Bizzoco; Letizia Corsani; Marco Gianfriddo; Felicita Pedata; Maria-Simonetta Faussone-Pellegrini
Relationships between neurons expressing neuronal nitric oxide synthase, degree of microglia activation and animal survival. A study in the rat cortex after transient ischemia.
Brain research 2007;1132(1):218-27.
2006: Carla Scali; Filippo Caraci; Marco Gianfriddo; Enrica Diodato; Renza Roncarati; Giuseppe Pollio; Giovanni Gaviraghi; Agata Copani; Ferdinando Nicoletti; Georg C Terstappen; Andrea Caricasole
Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1.
Neurobiology of disease 2006;24(2):254-65.
2006: Alessia Melani; Susanna Amadio; Marco Gianfriddo; Maria Giuliana Vannucchi; Cinzia Volontè; Giorgio Bernardi; Felicita Pedata; Giuseppe Sancesario
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2006;26(7):974-82.
2006: Alessia Melani; Marco Gianfriddo; Maria Giuliana Vannucchi; Sara Cipriani; Pier Giovanni Baraldi; Maria Grazia Giovannini; Felicita Pedata
The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia.
Brain research 2006;1073-1074():470-80.
2005: Alessia Melani; Daria Turchi; Maria Giuliana Vannucchi; Sara Cipriani; Marco Gianfriddo; Felicita Pedata
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.
Neurochemistry international 2005;47(6):442-8.
2005: Felicita Pedata; Marco Gianfriddo; Daria Turchi; Alessia Melani
The protective effect of adenosine A2A receptor antagonism in cerebral ischemia.
Neurological research 2005;27(2):169-74.
2005: Maria Giuliana Vannucchi; Letizia Corsani; Marco Gianfriddo; Felicita Pedata; Maria-Simonetta Faussone-Pellegrini
Expression of neuronal and inducible nitric oxide synthase in neuronal and glial cells after transient occlusion of the middle cerebral artery.
Neuroscience 2005;136(4):1015-26.
2004: Marco Gianfriddo; Alessia Melani; Daria Turchi; Maria Grazia Giovannini; Felicita Pedata
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow.
Neurobiology of disease 2004;17(1):77-88.
2003: Felicita Pedata; Anna Maria Pugliese; Alessia Melani; Marco Gianfriddo
A2A receptors in neuroprotection of dopaminergic neurons.
Neurology 2003;61(11 Suppl 6):S49-50.
2003: Marco Gianfriddo; Claudia Corsi; Alessia Melani; Antonella Pèzzola; Rosaria Reggio; Patrizia Popoli; Felicita Pedata
Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
Brain research 2003;979(1-2):225-9.
2003: Claudia Corsi; Annalisa Pinna; Marco Gianfriddo; Alessia Melani; Micaela Morelli; Felicita Pedata
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.
European journal of pharmacology 2003;464(1):33-8.
2003: Alessia Melani; Leonardo Pantoni; Francesca Bordoni; Marco Gianfriddo; Loria Bianchi; Maria Giuliana Vannucchi; Rosalia Bertorelli; Angela Monopoli; Felicita Pedata
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.
Brain research 2003;959(2):243-50.